Pellinen T - Search Results

1

Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.

Brück O, Blom S, Dufva O, Turkki R, Chheda H, Ribeiro A, Kovanen P, Aittokallio T, Koskenvesa P, Kallioniemi O, Porkka K, Pellinen T, Mustjoki S. Brück O, et al. Among authors: pellinen t. Leukemia. 2018 Jul;32(7):1643-1656. doi: 10.1038/s41375-018-0175-0. Epub 2018 Jun 20. Leukemia. 2018. PMID: 29925907 Free article.

2

A functional genetic screen reveals new regulators of β1-integrin activity.

Pellinen T, Rantala JK, Arjonen A, Mpindi JP, Kallioniemi O, Ivaska J. Pellinen T, et al. J Cell Sci. 2012 Feb 1;125(Pt 3):649-61. doi: 10.1242/jcs.090704. J Cell Sci. 2012. PMID: 22389402

3

Antibody-supervised deep learning for quantification of tumor-infiltrating immune cells in hematoxylin and eosin stained breast cancer samples.

Turkki R, Linder N, Kovanen PE, Pellinen T, Lundin J. Turkki R, et al. Among authors: pellinen t. J Pathol Inform. 2016 Sep 1;7:38. doi: 10.4103/2153-3539.189703. eCollection 2016. J Pathol Inform. 2016. PMID: 27688929 Free PMC article.

4

Orphan G protein-coupled receptor GPRC5A modulates integrin β1-mediated epithelial cell adhesion.

Bulanova DR, Akimov YA, Rokka A, Laajala TD, Aittokallio T, Kouvonen P, Pellinen T, Kuznetsov SG. Bulanova DR, et al. Among authors: pellinen t. Cell Adh Migr. 2017 Sep 3;11(5-6):434-446. doi: 10.1080/19336918.2016.1245264. Epub 2017 Feb 6. Cell Adh Migr. 2017. PMID: 27715394 Free PMC article.

5

Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.

Nagaraj AS, Lahtela J, Hemmes A, Pellinen T, Blom S, Devlin JR, Salmenkivi K, Kallioniemi O, Mäyränpää MI, Närhi K, Verschuren EW. Nagaraj AS, et al. Among authors: pellinen t. Cell Rep. 2017 Jan 17;18(3):673-684. doi: 10.1016/j.celrep.2016.12.059. Cell Rep. 2017. PMID: 28099846 Free article.

6

Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis.

Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki-Teeri P, Hemmes A, Välimäki K, Lundin J, Kallioniemi O, Pellinen T. Blom S, et al. Among authors: pellinen t. Sci Rep. 2017 Nov 14;7(1):15580. doi: 10.1038/s41598-017-15798-4. Sci Rep. 2017. PMID: 29138507 Free PMC article.

7

ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer.

Pellinen T, Blom S, Sánchez S, Välimäki K, Mpindi JP, Azegrouz H, Strippoli R, Nieto R, Vitón M, Palacios I, Turkki R, Wang Y, Sánchez-Alvarez M, Nordling S, Bützow A, Mirtti T, Rannikko A, Montoya MC, Kallioniemi O, Del Pozo MA. Pellinen T, et al. Sci Rep. 2018 Feb 5;8(1):2338. doi: 10.1038/s41598-018-20161-2. Sci Rep. 2018. PMID: 29402961 Free PMC article.

8

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA. Bruun J, et al. Among authors: pellinen t. Mol Oncol. 2018 Sep;12(9):1639-1655. doi: 10.1002/1878-0261.12347. Epub 2018 Aug 15. Mol Oncol. 2018. PMID: 29900672 Free PMC article.

9

PD-L1⁺ tumor-associated macrophages and PD-1⁺ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma.

Pollari M, Brück O, Pellinen T, Vähämurto P, Karjalainen-Lindsberg ML, Mannisto S, Kallioniemi O, Kellokumpu-Lehtinen PL, Mustjoki S, Leivonen SK, Leppä S. Pollari M, et al. Among authors: pellinen t. Haematologica. 2018 Nov;103(11):1908-1914. doi: 10.3324/haematol.2018.197194. Epub 2018 Jul 19. Haematologica. 2018. PMID: 30026337 Free PMC article. Clinical Trial.

10

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells.

Saeed K, Ojamies P, Pellinen T, Eldfors S, Turkki R, Lundin J, Järvinen P, Nisen H, Taari K, Af Hällström TM, Rannikko A, Mirtti T, Kallioniemi O, Östling P. Saeed K, et al. Among authors: pellinen t. Int J Cancer. 2019 Mar 15;144(6):1356-1366. doi: 10.1002/ijc.31815. Epub 2018 Nov 4. Int J Cancer. 2019. PMID: 30125350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters